Skip to main content

Scilex Holding Co

SCLXW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001820190

No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $16.4K in total; no superinvestor holds it.

Other share classesSCLX

Q4 2022 vs. Q3 2022

How the institutions holding Scilex Holding Co changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of SCLXW: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders026+26
Shares02.17M+2.17M
Value$0$356.1K+$356.1K

New holders (26)

Institutions that held Scilex Holding Co at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to SCLXW in Q4 2022
InstitutionSharesValue% of portfolio
Shaolin Capital Management LLC529,856$100.0K0.00%
Ionic Capital Management LLC194,244$36.7K0.01%
Polar Asset Management Partners Inc.174,232$33.1K0.00%
Balyasny Asset Management LLC150,000$28.3K0.00%
Rivernorth Capital Management, LLC121,291$23.0K0.00%
Jefferies Financial Group Inc.118,676$22.4K0.00%
Yakira Capital Management, Inc.104,999$19.8K0.00%
Walleye Capital LLC71,063$13.4K0.00%
CVI Holdings, LLC56,739$10.7K0.00%
Cruiser Capital Advisors, LLC49,999$9.45K0.01%
Crystalline Management Inc.48,771$9.21K0.00%
Walleye Trading LLC45,525$8.60K0.00%
Landscape Capital Management, L.L.C.43,824$8.28K0.00%
Wolverine Asset Management LLC41,288$7.80K0.00%
Context Capital Management, LLC27,499$5.00K0.00%
Atw Spac Management LLC26,416$4.99K0.00%
Privium Fund Management B.V.22,750$4.55K0.00%
Affinity Asset Advisors, LLC18,099$3.42K0.00%
Citadel Advisors LLC11,327$2.14K0.00%
Flow Traders U.S. LLC12,353$2.00K0.00%
HRT Financial LP12,917$2.00K0.00%
Kelly Financial Services LLC6,000$1.13K0.00%
Tower Research Capital LLC (TRC)418$00.00%
Radcliffe Capital Management, L.P.102,651––
Boothbay Fund Management, LLC26,416––
LMR Partners LLP150,000––

Sold out (0)

Institutions that held Scilex Holding Co at the end of Q3 2022 and filed for Q4 2022 without it.

None.